Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice

Antibiotic-induced shifts in the indigenous gut microbiota influence normal skeletal maturation. Current theory implies that gut microbiota actions on bone occur through a direct gut/bone signaling axis. However, our prior work supports that a gut/liver signaling axis contributes to gut microbiota e...

Full description

Bibliographic Details
Main Authors: Matthew D. Carson, Amy J. Warner, Jessica D. Hathaway-Schrader, Vincenza L. Geiser, Joseph Kim, Joy E. Gerasco, William D. Hill, John J. Lemasters, Alexander V. Alekseyenko, Yongren Wu, Hai Yao, J. Ignacio Aguirre, Caroline Westwater, Chad M. Novince
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-01-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.160578
_version_ 1797634352427827200
author Matthew D. Carson
Amy J. Warner
Jessica D. Hathaway-Schrader
Vincenza L. Geiser
Joseph Kim
Joy E. Gerasco
William D. Hill
John J. Lemasters
Alexander V. Alekseyenko
Yongren Wu
Hai Yao
J. Ignacio Aguirre
Caroline Westwater
Chad M. Novince
author_facet Matthew D. Carson
Amy J. Warner
Jessica D. Hathaway-Schrader
Vincenza L. Geiser
Joseph Kim
Joy E. Gerasco
William D. Hill
John J. Lemasters
Alexander V. Alekseyenko
Yongren Wu
Hai Yao
J. Ignacio Aguirre
Caroline Westwater
Chad M. Novince
author_sort Matthew D. Carson
collection DOAJ
description Antibiotic-induced shifts in the indigenous gut microbiota influence normal skeletal maturation. Current theory implies that gut microbiota actions on bone occur through a direct gut/bone signaling axis. However, our prior work supports that a gut/liver signaling axis contributes to gut microbiota effects on bone. Our purpose was to investigate the effects of minocycline, a systemic antibiotic treatment for adolescent acne, on pubertal/postpubertal skeletal maturation. Sex-matched specific pathogen–free (SPF) and germ-free (GF) C57BL/6T mice were administered a clinically relevant minocycline dose from age 6–12 weeks. Minocycline caused dysbiotic shifts in the gut bacteriome and impaired skeletal maturation in SPF mice but did not alter the skeletal phenotype in GF mice. Minocycline administration in SPF mice disrupted the intestinal farnesoid X receptor/fibroblast growth factor 15 axis, a gut/liver endocrine axis supporting systemic bile acid homeostasis. Minocycline-treated SPF mice had increased serum conjugated bile acids that were farnesoid X receptor (FXR) antagonists, suppressed osteoblast function, decreased bone mass, and impaired bone microarchitecture and fracture resistance. Stimulating osteoblasts with the serum bile acid profile from minocycline-treated SPF mice recapitulated the suppressed osteogenic phenotype found in vivo, which was mediated through attenuated FXR signaling. This work introduces bile acids as a potentially novel mediator of gut/liver signaling actions contributing to gut microbiota effects on bone.
first_indexed 2024-03-11T12:06:28Z
format Article
id doaj.art-3d9af3f7271a4cf4a793aa66405e8d7f
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:06:28Z
publishDate 2023-01-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-3d9af3f7271a4cf4a793aa66405e8d7f2023-11-07T16:25:02ZengAmerican Society for Clinical investigationJCI Insight2379-37082023-01-0181Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in miceMatthew D. CarsonAmy J. WarnerJessica D. Hathaway-SchraderVincenza L. GeiserJoseph KimJoy E. GerascoWilliam D. HillJohn J. LemastersAlexander V. AlekseyenkoYongren WuHai YaoJ. Ignacio AguirreCaroline WestwaterChad M. NovinceAntibiotic-induced shifts in the indigenous gut microbiota influence normal skeletal maturation. Current theory implies that gut microbiota actions on bone occur through a direct gut/bone signaling axis. However, our prior work supports that a gut/liver signaling axis contributes to gut microbiota effects on bone. Our purpose was to investigate the effects of minocycline, a systemic antibiotic treatment for adolescent acne, on pubertal/postpubertal skeletal maturation. Sex-matched specific pathogen–free (SPF) and germ-free (GF) C57BL/6T mice were administered a clinically relevant minocycline dose from age 6–12 weeks. Minocycline caused dysbiotic shifts in the gut bacteriome and impaired skeletal maturation in SPF mice but did not alter the skeletal phenotype in GF mice. Minocycline administration in SPF mice disrupted the intestinal farnesoid X receptor/fibroblast growth factor 15 axis, a gut/liver endocrine axis supporting systemic bile acid homeostasis. Minocycline-treated SPF mice had increased serum conjugated bile acids that were farnesoid X receptor (FXR) antagonists, suppressed osteoblast function, decreased bone mass, and impaired bone microarchitecture and fracture resistance. Stimulating osteoblasts with the serum bile acid profile from minocycline-treated SPF mice recapitulated the suppressed osteogenic phenotype found in vivo, which was mediated through attenuated FXR signaling. This work introduces bile acids as a potentially novel mediator of gut/liver signaling actions contributing to gut microbiota effects on bone.https://doi.org/10.1172/jci.insight.160578Bone biologyEndocrinology
spellingShingle Matthew D. Carson
Amy J. Warner
Jessica D. Hathaway-Schrader
Vincenza L. Geiser
Joseph Kim
Joy E. Gerasco
William D. Hill
John J. Lemasters
Alexander V. Alekseyenko
Yongren Wu
Hai Yao
J. Ignacio Aguirre
Caroline Westwater
Chad M. Novince
Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
JCI Insight
Bone biology
Endocrinology
title Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
title_full Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
title_fullStr Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
title_full_unstemmed Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
title_short Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
title_sort minocycline induced disruption of the intestinal fxr fgf15 axis impairs osteogenesis in mice
topic Bone biology
Endocrinology
url https://doi.org/10.1172/jci.insight.160578
work_keys_str_mv AT matthewdcarson minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT amyjwarner minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT jessicadhathawayschrader minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT vincenzalgeiser minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT josephkim minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT joyegerasco minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT williamdhill minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT johnjlemasters minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT alexandervalekseyenko minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT yongrenwu minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT haiyao minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT jignacioaguirre minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT carolinewestwater minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice
AT chadmnovince minocyclineinduceddisruptionoftheintestinalfxrfgf15axisimpairsosteogenesisinmice